MedTrace Logo

Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline

NCT03903029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242

Last updated 2026-04-27

No results posted yet for this study

Summary

This study aimed to evaluate the efficacy of low-dose rosuvastatin (10 mg) in the 4 statin benefit groups requiring high- or moderate-intensity statin therapy according to the 2013 American College of Cardiology/American Heart Association guideline in Korean population.

Conditions

  • Dyslipidemias

Interventions

DRUG

Low-dose (10mg) rosuvastatin

Low-dose (10mg) rosuvastatin in 4 statin benefit groups per 2013 ACC/AHA guideline

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hyo-Soo Kim, MD., PhD. · Seoul National University Hospital

Eligibility

Min Age
21 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-10
Primary Completion
2016-07-05
Completion
2019-12-05

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903029 on ClinicalTrials.gov